Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» antibody-drug conjugate
antibody-drug conjugate
BioNTech Adds Two ADCs in Second Deal in as Many Months
BioSpace
Mon, 04/3/23 - 10:44 pm
BioNTech
antibody-drug conjugate
solid tumors
Duality Biologics
Takeda opens 4th front in assault on celiac, tapping Innate to develop antibody-drug conjugates
Fierce Biotech
Mon, 04/3/23 - 09:44 am
Takeda
celiac disease
antibody-drug conjugate
Innate Pharma
AbbVie sidelines CytomX after seeing midphase oncology ADC data, opens talks on returning lead drug
Fierce Biotech
Tue, 03/28/23 - 10:22 am
AbbVie
CytomX Therapeutics
cancer
oncology
antibody-drug conjugate
FDA pauses Mersana’s clinical trial after patient dies
Endpoints
Mon, 03/13/23 - 10:54 am
Mersana
clinical trials
FDA
patient death
cancer
XMT-2056
antibody-drug conjugate
Vertex pays ImmunoGen $15M to use antibody-drug conjugates to improve CRISPR therapy
Fierce Biotech
Wed, 03/1/23 - 09:56 am
Vertex Pharmaceuticals
Immunogen
gen editing
antibody-drug conjugate
exa-cel
AstraZeneca strengthens its oncology R&D with in-licensing of CMG901 from China-based biotech KYM Biosciences
Medical Marketing and Media
Fri, 02/24/23 - 09:16 am
AstraZeneca
CMG901
antibody-drug conjugate
gastric cancer
KYM Biosciences
AstraZeneca doubles down on hot cancer target, paying $63M for ADC months after bispecific deal
Fierce Biotech
Thu, 02/23/23 - 10:00 am
AstraZeneca
Claudin18.2
KYM Biosciences
antibody-drug conjugate
pancreatic cancer
In flux, CDMO Abzena lays off 66 in San Diego days after hiring new CEO and reshuffling board
Fierce Pharma
Fri, 01/27/23 - 10:33 am
Abzena
CDMOs
layoffs
antibody-drug conjugate
Sutro shells out latest update on ovarian cancer treatment, plans for pivotal trial
Endpoints
Tue, 01/10/23 - 10:54 am
Sutro BioPharma
clinical trials
antibody-drug conjugate
ovarian cancer
luveltamab tazevibulin
Amgen piles $2B more into pharma's ADC rush in Synaffix pact
Fierce Biotech
Thu, 01/5/23 - 04:42 pm
Amgen
antibody-drug conjugate
Synaffix
ADC deals: Mersana engages with Merck, LegoChem and Amgen collaborate
Biopharma Reporter
Mon, 01/2/23 - 06:41 pm
antibody-drug conjugate
Merck
LegoChem Biosciences
Mersana
Amgen
GSK
Janssen
Merck Expands ADC Footprint with $9.3B Kelun Licensing Deal
BioSpace
Thu, 12/22/22 - 10:44 am
Merck
China
Kelun-Biotech
antibody-drug conjugate
oncology
Chasing Gilead, AstraZeneca-Daiichi lay down phase 2 breast cancer data for antibody-drug conjugate
Fierce Biotech
Fri, 12/9/22 - 10:46 am
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Gilead Sciences
Exelixis Inks Third Collaboration Deal in a Week, This Time with Catalent
BioSpace
Thu, 11/3/22 - 07:34 pm
Exelixis
Catalent
antibody-drug conjugate
Mablink Breaks into ADC Space with $30M for Improved Linker Tech
BioSpace
Sun, 10/16/22 - 05:14 pm
Mablink
antibody-drug conjugate
MBK-103
cancer
Synaffix rustles up another ADC deal, allying with Emergence in $360M biobuck pact
Fierce Biotech
Wed, 09/7/22 - 10:29 am
Synaffix
Emergence Therapeutics
antibody-drug conjugate
Uncertainty at Ambrx as biotech loses CEO, takes hard look at pipeline
Fierce Biotech
Wed, 08/17/22 - 11:01 am
Ambrx
Bristol Myers Squibb
antibody-drug conjugate
GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep
Fierce Biotech
Mon, 08/8/22 - 11:45 pm
GSK
Mersana
antibody-drug conjugate
Blenrep
XMT-2056
Merck picks up another ADC agreement
Biopharma Reporter
Tue, 08/2/22 - 10:50 am
Merck
antibody-drug conjugate
Sichuan Kelun Pharmaceutical
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Endpoints
Thu, 07/28/22 - 06:32 pm
Elevation Oncology
gastric cancer
pancreatic cancer
antibody-drug conjugate
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »